secwatch.observer — SEC 8-K summary
======================================

Issuer:     Invitae Corp (—)
CIK:        0001501134
Form:       8-K
Filed at:   2024-01-22T23:59:59+00:00
Accession:  0001501134-24-000007
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 2.01, 2.05, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Invitae sells reproductive health assets to Natera for up to $52.5M
-------------------------------------------------------------------

- Upfront $10M cash; up to $20M litigation credits/cash from Natera v. ArcherDx case; up to $22.5M retention milestone.
- Natera hires Invitae reproductive health sales reps; transitions carrier screening and NIPT customers.
- Non-compete on testing services until March 2027; transition services through July 2024.
- Workforce reduction; expects $44M annualized OpEx cash savings from sale, excluding severance.
- Past damages cap of $20M for infringing sales in Natera v. ArcherDx case.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1501134/000150113424000007/0001501134-24-000007-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1501134/000150113424000007/nvta-20240117.htm
  HTML page:      https://secwatch.observer/filing/0001501134-24-000007

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer